Delving into the Latest Updates on Anesta AG with Synapse

Overview

Tags

Congenital Disorders

Nervous System Diseases

Other Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

VMAT2(Synaptic vesicular amine transporter)	1

Primary objective: To evaluate the effectiveness of deutetrabenazine in treating adult patients with chorea associated with Huntington's disease in the real world of China. Secondary objective: To evaluate the safety of deutetrabenazine in treating adult patients with chorea associated with Huntington's disease in the real world of China.

Start Date-

Sponsor / Collaborator

Anesta AG

[+2]

CTR20233248 / CompletedPhase 1

一项评价单次给药12 mg安泰坦®片剂在健康中国受试者中的氘丁苯那嗪及其活性代谢物的药代动力学特征的开放性、单剂量研究

[Translation] An open-label, single-dose study evaluating the pharmacokinetic profile of deutetrabenazine and its active metabolite in healthy Chinese subjects after a single 12 mg dose of Antaetan® tablets

评价健康中国男性和女性受试者餐后单次口服12 mg TEV-50717片剂后TEV-50717（母体药物）及其活性氘代代谢物α-二氢丁苯那嗪（α-HTBZ）和β-二氢丁苯那嗪（β-HTBZ）（总和及单个成分）的药代动力学特征。

[Translation]

To evaluate the pharmacokinetic profiles of TEV-50717 (parent drug) and its active deuterated metabolites α-dihydrotetrabenazine (α-HTBZ) and β-dihydrotetrabenazine (β-HTBZ) (total and individual components) after a single oral dose of 12 mg TEV-50717 tablets in healthy Chinese male and female subjects after a meal.

Start Date01 Nov 2023

Sponsor / Collaborator

Anesta AG

[+2]

100 Clinical Results associated with Anesta AG

Login to view more data

0 Patents (Medical) associated with Anesta AG

Login to view more data

100 Deals associated with Anesta AG

Login to view more data

100 Translational Medicine associated with Anesta AG

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data